These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35678022)

  • 21. Predictive significance of serum dipeptidyl peptidase-IV in papillary thyroid carcinoma.
    Zhang N; Cong X; Zhou D; Guo L; Yuan C; Xu D; Su C
    Cancer Biomark; 2019; 24(1):7-17. PubMed ID: 30594915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating pre- and post-operation plasma miRNAs of papillary thyroid carcinoma (PTC) patients in comparison to benign nodules.
    Rezaei M; Khamaneh AM; Zarghami N; Vosoughi A; Hashemzadeh S
    BMC Cancer; 2019 Jul; 19(1):690. PubMed ID: 31307429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic value of microRNAs in discriminating malignant thyroid nodules from benign ones on fine-needle aspiration samples.
    Zhang Y; Zhong Q; Chen X; Fang J; Huang Z
    Tumour Biol; 2014 Sep; 35(9):9343-53. PubMed ID: 24943685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression Levels of miR-30a-5p in Papillary Thyroid Carcinoma: A Comparison Between Serum and Fine Needle Aspiration Biopsy Samples.
    Igci YZ; Ozkaya M; Korkmaz H; Bozgeyik E; Bayraktar R; Ulasli M; Erkilic S; Eraydin A; Oztuzcu S
    Genet Test Mol Biomarkers; 2015 Aug; 19(8):418-23. PubMed ID: 26047355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Prognostic Biomarkers in Papillary Thyroid Cancer and Developing Non-Invasive Diagnostic Models Through Integrated Bioinformatics Analysis.
    Oskouie AA; Ahmadi MS; Taherkhani A
    Microrna; 2022; 11(1):73-87. PubMed ID: 35068400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrative metabolomic characterization identifies plasma metabolomic signature in the diagnosis of papillary thyroid cancer.
    Yu S; Liu C; Hou Y; Li J; Guo Z; Chen X; Zhang L; Peng S; Hong S; Xu L; Li X; Liu R; Chen S; Li B; Weng Z; Li Y; Lv W; Yu J; Xiao H
    Oncogene; 2022 Apr; 41(17):2422-2430. PubMed ID: 35279704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of plasma exosomal miRNAs as potential diagnostic biomarkers of lymph node metastasis in papillary thyroid carcinoma.
    Chen W; Li G; Li Z; Zhu J; Wei T; Lei J
    Endocrine; 2022 Mar; 75(3):846-855. PubMed ID: 34854020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discriminatory miRNAs for the Management of Papillary Thyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features.
    Jahanbani I; Al-Abdallah A; Ali RH; Al-Brahim N; Mojiminiyi O
    Thyroid; 2018 Mar; 28(3):319-327. PubMed ID: 29378472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Role of Claudin-1 on diagnostic cut-off value and multiple tests in patients with papillary thyroid carcinoma].
    Hou WD; Ding HX; Li HM; Wang JH; Liu YF
    Zhonghua Yi Xue Za Zhi; 2021 Jul; 101(28):2233-2237. PubMed ID: 34333937
    [No Abstract]   [Full Text] [Related]  

  • 30. Aberrant expression of five miRNAs in papillary thyroid carcinomas.
    Qiao DH; He XM; Deng X; Ji YC; Yang H; Cheng L; Zhou XY
    J Clin Lab Anal; 2021 Sep; 35(9):e23907. PubMed ID: 34268792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating microRNAs and Clinicopathological Findings of Papillary Thyroid Cancer: A Systematic Review.
    Geropoulos G; Psarras K; Papaioannou M; Giannis D; Meitanidou M; Kapriniotis K; Symeonidis N; Pavlidis ET; Pavlidis TE; Sapalidis K; Ahmed NM; Abdel-Aziz TE; Eddama MMR
    In Vivo; 2022; 36(4):1551-1569. PubMed ID: 35738604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative platelet distribution width-to-platelet ratio combined with serum thyroglobulin may be objective and popularizable indicators in predicting papillary thyroid carcinoma.
    Jin J; Wu G; Ruan C; Ling H; Zheng X; Ying C; Zhang Y
    J Clin Lab Anal; 2022 Jun; 36(6):e24443. PubMed ID: 35441746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic monitoring of circulating microRNAs as a predictive biomarker for the diagnosis and recurrence of papillary thyroid carcinoma.
    Zhang Y; Xu D; Pan J; Yang Z; Chen M; Han J; Zhang S; Sun L; Qiao H
    Oncol Lett; 2017 Jun; 13(6):4252-4266. PubMed ID: 28599426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined staining for immunohistochemical markers in the diagnosis of papillary thyroid carcinoma: improvement in the sensitivity or specificity?
    Wu G; Wang J; Zhou Z; Li T; Tang F
    J Int Med Res; 2013 Aug; 41(4):975-83. PubMed ID: 23857157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical diagnostic value of American College of Radiology thyroid imaging report and data system in different kinds of thyroid nodules.
    Zhang Z; Lin N
    BMC Endocr Disord; 2022 May; 22(1):145. PubMed ID: 35642030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic Value of Serum Cytokeratin 18, Carcinoembryonic Antigen, and Thyroglobulin in Patients with Papillary Thyroid Carcinoma.
    Yan G; Zhou Y; Wu H; Xun H
    Clin Lab; 2021 Feb; 67(2):. PubMed ID: 33616340
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Li J; Yin Y; Huang H; Li M; Li H; Zhang M; Jiang C; Yang R
    Epigenomics; 2023 Dec; 15(23):1257-1272. PubMed ID: 38126720
    [No Abstract]   [Full Text] [Related]  

  • 38. Methylation markers differentiate thyroid cancer from benign nodules.
    Stephen JK; Chen KM; Merritt J; Chitale D; Divine G; Worsham MJ
    J Endocrinol Invest; 2018 Feb; 41(2):163-170. PubMed ID: 28612287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma.
    Evranos B; Polat SB; Baser H; Ozdemir D; Kilicarslan A; Yalcin A; Ersoy R; Cakir B
    Cytopathology; 2017 Aug; 28(4):259-267. PubMed ID: 27666595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomarker Value of miR-221 and miR-222 as Potential Substrates in the Differential Diagnosis of Papillary Thyroid Cancer Based on Data Synthesis and Bioinformatics Approach.
    Cai S; Ma J; Wang Y; Cai Y; Xie L; Chen X; Yang Y; Peng Q
    Front Endocrinol (Lausanne); 2021; 12():794490. PubMed ID: 35197926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.